Patient not adequately controlled with insulin therapy and hospitalized for congestive heart failure

Paziente non adeguatamente controllato con terapia insulinica e ricoverato per scompenso cardiaco congestizio

Authors

  • Vera Frison UOC Medicina Generale, Servizio di Diabetologia, AULSS 6 Euganea, PO Cittadella, Cittadella (Padova) - Italy
  • Alessio Filippi UOC Medicina Generale, Servizio di Diabetologia, AULSS 6 Euganea, PO Cittadella, Cittadella (Padova) - Italy
  • Natalino Simioni UOC Medicina Generale, Servizio di Diabetologia, AULSS 6 Euganea, PO Cittadella, Cittadella (Padova) _ Italy

DOI:

https://doi.org/10.19156/abtpn.2018.0052

Keywords:

Type 2 diabetes, Congestive heart failure, Empagliflozin

Abstract

The data provided by cardiovascular safety studies of type 2 sodium-glucose transporter inhibitors have aroused great interest among diabetologists and other specialists. They demonstrated that these drugs reduce significantly, compared to placebo, the risk of major cardiovascular events, all cause and cardiovascular mortality, and hospitalization for heart failure in patients with type 2 diabetes at high cardiovascular risk. We report the case of a cardiovascular diabetic patient not adequately controlled by high-dose multi-injective insulin therapy and hospitalized for congestive heart failure, treated with empagliflozin in association with high doses of loop diuretic (furosemide) and sacubitril/valsartan (Diabetology).

Downloads

Download data is not yet available.

Downloads

Published

2018-08-29

How to Cite

Frison, V., Filippi, A., & Simioni, N. (2018). Patient not adequately controlled with insulin therapy and hospitalized for congestive heart failure: Paziente non adeguatamente controllato con terapia insulinica e ricoverato per scompenso cardiaco congestizio. AboutOpen, 4(1), 96–99. https://doi.org/10.19156/abtpn.2018.0052

Issue

Vol. 4 No. 1 (2018): January - December 2018

Section

Case report

License

Copyright (c) 2018 The authors

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors contributing to AboutOpen agree to publish their articles under the Creative Commons NonCommercial 4.0 International License (CC BY-NC 4.0), which allows third parties to copy and redistribute the material providing appropriate credit and a link to the license but does not allow to use the material for commercial purposes and to use the material if it has been remixed, transformed or built upon. 

Metrics

Crossref
Scopus
Google Scholar
Europe PMC